Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Bone Marrow Transplant in Diabetes
NCT03562208Phase 3Unknown
- Start
- Jan 2018
- Primary completion
- Jan 2020
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 3 trial of autologous bone marrow stem cells in type 1 diabetes mellitus (T1D), type 2 diabetes mellitus (T2DM). Status: unknown.
02
Drugs
autologous bone marrow stem cells
03
Conditions
type 1 diabetes mellitus (T1D)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03562208.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03562208.